Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.

IF 3.2 Q2 CLINICAL NEUROLOGY
Francesco Sartori, Albert Puig-Diví, Javier Picañol
{"title":"Ultrasound-Guided Percutaneous Nerve Stimulation in Post-Stroke Spasticity: A Case Report.","authors":"Francesco Sartori, Albert Puig-Diví, Javier Picañol","doi":"10.3390/neurolint17030034","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors. While various treatments exist, options for refractory cases are limited. Ultrasound-guided percutaneous peripheral nerve stimulation (pPNS), commonly used in pain management, has not been studied for its potential use in spasticity management. This case report aims to evaluate the sensorimotor effects of pPNS in a patient with severe PSS.</p><p><strong>Case description: </strong>A 38-year-old male with severe PSS and functional limitations post-ischemic stroke in the middle cerebral artery underwent a six-week pPNS protocol (12 sessions). Low-frequency (2 Hz) stimulation targeted the median, musculocutaneous, and anterior interosseous nerves, while medium-frequency (10 Hz) stimulation targeted the posterior interosseous and radial nerves. Spasticity was assessed using the Modified Ashworth Scale (MAS) and Tardieu Scale (TS). Somatosensory assessments included tactile thresholds, pressure pain thresholds, and conditioned pain modulation (CPM).</p><p><strong>Outcomes: </strong>Spasticity decreased significantly, with reductions of 60.4% and 67.0% in elbow and wrist MAS scores, respectively, and a 49.5% reduction in TS scores. However, spasticity levels returned to baseline between sessions. Somatosensory assessments revealed increased tactile thresholds, decreased pressure pain thresholds, and an 81.3% reduction in CPM. The intervention was well tolerated, with minor transient effects, and the patient preferred pPNS over botulinum toxin injections.</p><p><strong>Conclusions: </strong>pPNS may effectively reduce spasticity and modulate somatosensory thresholds in PSS. These preliminary findings highlight its potential as an alternative treatment for refractory PSS, warranting further research with larger sample sizes and control groups to assess its broader clinical applicability.</p>","PeriodicalId":19130,"journal":{"name":"Neurology International","volume":"17 3","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2025-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11944408/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Neurology International","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3390/neurolint17030034","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Post-stroke spasticity (PSS) significantly impacts the quality of life for stroke survivors. While various treatments exist, options for refractory cases are limited. Ultrasound-guided percutaneous peripheral nerve stimulation (pPNS), commonly used in pain management, has not been studied for its potential use in spasticity management. This case report aims to evaluate the sensorimotor effects of pPNS in a patient with severe PSS.

Case description: A 38-year-old male with severe PSS and functional limitations post-ischemic stroke in the middle cerebral artery underwent a six-week pPNS protocol (12 sessions). Low-frequency (2 Hz) stimulation targeted the median, musculocutaneous, and anterior interosseous nerves, while medium-frequency (10 Hz) stimulation targeted the posterior interosseous and radial nerves. Spasticity was assessed using the Modified Ashworth Scale (MAS) and Tardieu Scale (TS). Somatosensory assessments included tactile thresholds, pressure pain thresholds, and conditioned pain modulation (CPM).

Outcomes: Spasticity decreased significantly, with reductions of 60.4% and 67.0% in elbow and wrist MAS scores, respectively, and a 49.5% reduction in TS scores. However, spasticity levels returned to baseline between sessions. Somatosensory assessments revealed increased tactile thresholds, decreased pressure pain thresholds, and an 81.3% reduction in CPM. The intervention was well tolerated, with minor transient effects, and the patient preferred pPNS over botulinum toxin injections.

Conclusions: pPNS may effectively reduce spasticity and modulate somatosensory thresholds in PSS. These preliminary findings highlight its potential as an alternative treatment for refractory PSS, warranting further research with larger sample sizes and control groups to assess its broader clinical applicability.

超声引导下经皮神经刺激治疗脑卒中后痉挛1例。
脑卒中后痉挛(PSS)显著影响脑卒中幸存者的生活质量。虽然存在各种治疗方法,但难治性病例的选择有限。超声引导下经皮周围神经刺激(pPNS)通常用于疼痛治疗,但尚未研究其在痉挛治疗中的潜在应用。本病例报告旨在评估pPNS对严重PSS患者的感觉运动效果。病例描述:一名患有严重PSS和大脑中动脉缺血性卒中后功能限制的38岁男性接受了为期6周的pPNS治疗方案(12个疗程)。低频(2hz)刺激针对正中神经、肌皮神经和前骨间神经,而中频(10hz)刺激针对后骨间神经和桡骨神经。采用改良Ashworth量表(MAS)和Tardieu量表(TS)评估痉挛性。躯体感觉评估包括触觉阈值、压力疼痛阈值和条件疼痛调节(CPM)。结果:痉挛明显减少,肘部和腕部MAS评分分别降低60.4%和67.0%,TS评分降低49.5%。然而,痉挛水平在疗程之间恢复到基线水平。体感觉评估显示触觉阈值增加,压痛阈值降低,CPM降低81.3%。干预耐受性良好,有轻微的短暂影响,患者更喜欢pPNS而不是肉毒杆菌毒素注射。结论:pPNS可有效减轻PSS患者的痉挛,调节躯体感觉阈值。这些初步发现强调了其作为难治性PSS的替代治疗方法的潜力,需要进一步研究更大的样本量和对照组来评估其更广泛的临床适用性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Neurology International
Neurology International CLINICAL NEUROLOGY-
CiteScore
3.70
自引率
3.30%
发文量
69
审稿时长
11 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信